Results 121 to 130 of about 1,807 (174)

Un ensayo clínico no ético y la politización de la pandemia de COVID-19 en Brasil: El caso de Prevent Senior. [PDF]

Dev World Bioeth
Hellmann F, Homedes N.
europepmc   +1 more source

Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity? [PDF]

Med Clin (Barc), 2020
Lasheras I, Santabárbara J.
europepmc   +1 more source

[Pharmacological treatment in uncertainty times: Hydroxychloroquine/chloroquine use in the COVID-19 treatment]. [PDF]

Semergen, 2020
Mayayo-Vicente S, Rodriguez Salvanés F, Gallego-Arenas A, Sánchez-Gómez LM, Ruiz-López M, Sierra García B, Jurado-López A, Arriola-Bolado P, Cervera Cano M, Novella-Arribas B.   +9 more
europepmc   +1 more source

Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines. [PDF]

Rev Saude Publica
Brito Junior I, Saraiva FA, Bruno NC, Silva RFD, Hino CM, Yoshizaki HTY.   +5 more
europepmc   +1 more source

[DRESS Syndrome in a Patient With SARS-CoV-2 Disease]. [PDF]

Open Respir Arch, 2020
Riveiro V, Rodríguez-Núñez N, Méndez-Brea P, Valdés L.   +3 more
europepmc   +1 more source

[Lupus Cheilitis: a clinical case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Mendez-Flores S, Palafox-Romo R, Esquivel-Pedraza L.   +2 more
europepmc   +1 more source

Current treatment of lupus nephritis: an overview of the new guidelines. [PDF]

J Bras Nefrol
Sales GTM, Macedo NJ, Reis Neto ETD, Kirsztajn GM.   +3 more
europepmc   +1 more source

Covid-19, desinformação e Facebook: circulação de URLs sobre a hidroxicloroquina em páginas e grupos públicos

, 2020
Soares FB, Viegas P, Bonoto C, Recuero R.   +3 more
europepmc   +1 more source

[Epidemiological, clinical, and biochemical characteristics of patients in the LUPUS-IMMex cohort]. [PDF]

Rev Med Inst Mex Seguro Soc
Ocampo-Torres MC, Bravo-Rojas FM, Martínez-Badajoz A, Hernández-Vásquez R, Ramírez-Pérez AA, Camargo-Coronel A, Vázquez-Zaragoza MÁ, Luna-Peña E, Pazos-Pérez F, Hernández-Rivera JCH.   +9 more
europepmc   +1 more source